Elsevier

Lung Cancer

Volume 34, Supplement 2, December 2001, Pages S109-S113
Lung Cancer

Endobronchial ultrasound

https://doi.org/10.1016/S0169-5002(01)00349-XGet rights and content

Abstract

Endobronchial ultrasound (EBUS) is a new diagnostic tool, which has expanded the view of the bronchoscopist beyond the confinements of the airways. It has great potential for diagnosis of mediastinal processes and staging of lung cancer. These will be discussed and illustrated. EBUS will become a superior tool for staging of lung cancer, and several comparative studies on EBUS as compared with standard techniques in order to assess its role in the staging procedure are just on their way or already completed.

Introduction

The endobronchial application of ultrasound has first been described in 1992 [1]. The following years technical difficulties had to be solved and a clear view on the indication and diagnostic properties of endobronchial ultrasound (EBUS) had to be developed. Currently, since 1999 EBUS is commercially available and is gradually introduced in the bronchoscopic practice. This has broadened the view of the bronchoscopist and augmented the diagnostic possibilities for both bronchial and mediastinal pathology.

Some aspects have yet to be assessed when the technique is spread more widely. The investment for the equipment of currently approximately 50 000–80 000 EURO seems to be reasonable considering the wide range of indications that includes up to 50% of all regular bronchoscopies for additional information. Refunding, however, currently is still not yet awarded universally. Considering the fact that it takes at least 50 sessions to acquire basic experience even in regular diagnostic bronchoscopy [2] it takes considerably more effort to gain expertise in this new diagnostic method, showing structures like the tracheal wall that were not available for diagnosis up to now, and imaging mediastinal structures from uncommon angles and points of view [3], [4]. Thus besides basic instruction some time of continuous coaching seems to be important. Currently, new ways of tele-teaching for this period are under investigation.

For optimal imaging the miniaturized 20 MHz US probes that we apply (Olympus UM-BS20-26R) are fitted with a catheter that carries a water-inflatable balloon at the tip. Once inflated, this optimizes the contact between the probe and the bronchial wall and allows acquisition of detailed images of the surrounding structures. Complete occlusion of major airways rarely causes considerable discomfort, but is usually well tolerated even under local anesthesia [3], [5]. Obstruction of the main bronchi did not compel to interrupt the procedure as long as the other side is well ventilated. Sometimes although cough might increase during inflation of the balloon [1]. General anesthesia has the advantage of allowing apnea for up to 3 min, which provides enough time to obtain information on airways and mediastinal structures.

Section snippets

Sonographic airway anatomy

The ultrasonographic structure of the cartilaginous portion of the wall of the trachea and the central bronchi is described as a five or seven layer structure by different authors [6], [7]. The original publication of Hürter and Hanrath mentioned a three layered pattern for the lobar bronchial wall containing cartilage [1]. Kurimoto defined the anatomical substrate of ultrasonic structures by comparing the ultrasound image with the histopathologic image after sticking needles into the different

Indications

The indications for EBUS have been extensively studied but so far only in a limited number of institutions EBUS is used regularly in daily practice. Its greatest potential lies in staging of lung cancer, diagnosis of mediastinal processes and diagnosis of peripheral intrapulmonary lesions (Table 1).

Mediastinal processes can be located precisely, with special attention to their relation to mediastinal structures. EBUS seems more suitable to detect infiltration of mediastinal organs by tumor,

Staging of lung cancer

The contribution of EBUS to the staging of lung cancer concerns both the local tumor (T), the lymph node involvement (N) and might even confirm the presence of pulmonary metastases (M).

Pre-malignant lesions or small intrabronchial tumors are usually detected accidentally in patients who are investigated for other clinical reasons. Recently new methods for screening (autofluorescence bronchoscopy/AF) in patients at risk for developing bronchial carcinoma have been introduced, as conventional

Peripheral lesions

The use of EBUS for investigation of the lung parenchyma is severely hampered by total reflection of the ultrasound signal due to air. However, due to their difference in echogeneity solid processes can be precisely located by EBUS, and to our experience in many cases can replace fluoroscopy for guiding bioptic procedures. Furthermore analysis of the structure of the lesion by EBUS might provide additional insight into the nature of peripheral abnormalities, as different lesions such as

Conclusion

From our current experience we are confident that in the future the value of EBUS as diagnostic tool for both mediastinal abnormalities and the staging of lung cancer will be further established. As experience grows and teaching will be more readily available an increasing number of bronchoscopists will gain experience with this new endobronchial technique and the role of EBUS in diagnostic bronchoscopy will expand. An increasing number of prospective data describing the diagnostic properties

References (17)

There are more references available in the full text version of this article.

Cited by (27)

  • Role of ultrasound-guided transbronchial biopsy in the diagnosis of peripheral pulmonary lesions

    2013, Lung Cancer
    Citation Excerpt :

    Although lung cancer might be suspected on some radiological features of the lesion, a histological diagnosis is often mandatory and needs invasive approaches [1]. In this setting, bronchoscopy is usually performed and endobronchial ultrasound (EBUS) can be used as a valid alternative to fluoroscopy in providing an image guidance for transbronchial biopsy (TBB) [2,3]. It is known that EBUS-guided TBB has a higher diagnostic accuracy than TBB without any guidance in the diagnosis of PPLs [4].

  • Endobronchial ultrasonography with distance for peripheral pulmonary lesions

    2007, Respiratory Medicine
    Citation Excerpt :

    Endobronchial ultrasonography (EBUS), first introduced in 1990 by Hurter and Hanrath, has been evaluated in several clinical studies and shown to provide information about the location and size of pulmonary lesions.1–3

  • Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions

    2005, Chest
    Citation Excerpt :

    Its sensitivity is low, and a negative result cannot rule out the presence of a malignancy. The possibility of using ultrasound has widened the bronchoscopic vision beyond the bronchial wall, with a substantial increase in diagnostic sensitivity.11 While the role of EBUS-driven biopsies in central malignancy diagnosis or in the evaluation of lymph nodes involvement is well established, there are few studies investigating its role in the diagnosis of peripheral lesions.

  • Ultrasound in Pulmonology: The Current Situation

    2003, Archivos de Bronconeumologia
  • The restaging issue

    2003, Lung Cancer
View all citing articles on Scopus
1

On behalf of the The Rotterdam Oncologic Thoracic Study group, ROTS

View full text